SRPT actually surged 35% directly, the rare disease direction is causing trouble again 😰 To be honest, I thought innovative drugs and the like had already reached their limit, who knew there could still be a bounce. After missing it, I can only sigh looking at my account.
LLY also had some recent recovery after a continuous downtrend, but I always feel the sentiment in the pharmaceutical sector is just extreme. Holding it makes my heart race, not holding it makes me greedy.
TERN's new drug had a small gain over there, giving a bit of hope.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
